GR3036978T3 - Anthracycline conjugates, their preparation and their use as antitumor agents. - Google Patents

Anthracycline conjugates, their preparation and their use as antitumor agents.

Info

Publication number
GR3036978T3
GR3036978T3 GR20010401848T GR20010401848T GR3036978T3 GR 3036978 T3 GR3036978 T3 GR 3036978T3 GR 20010401848 T GR20010401848 T GR 20010401848T GR 20010401848 T GR20010401848 T GR 20010401848T GR 3036978 T3 GR3036978 T3 GR 3036978T3
Authority
GR
Greece
Prior art keywords
pct
mol
image
preparation
residue
Prior art date
Application number
GR20010401848T
Other languages
Greek (el)
English (en)
Inventor
Francesco Angelucci
Maria Grandi
Antonino Suarato
Original Assignee
Pharmacia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Spa filed Critical Pharmacia Spa
Publication of GR3036978T3 publication Critical patent/GR3036978T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyamides (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GR20010401848T 1993-05-11 2001-10-22 Anthracycline conjugates, their preparation and their use as antitumor agents. GR3036978T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939309663A GB9309663D0 (en) 1993-05-11 1993-05-11 Biologically active compounds
PCT/EP1994/001100 WO1994026311A1 (en) 1993-05-11 1994-04-08 Anthracycline conjugates, their preparation and their use as antitumor agents

Publications (1)

Publication Number Publication Date
GR3036978T3 true GR3036978T3 (en) 2002-01-31

Family

ID=10735264

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010401848T GR3036978T3 (en) 1993-05-11 2001-10-22 Anthracycline conjugates, their preparation and their use as antitumor agents.

Country Status (25)

Country Link
US (1) US5571785A (cg-RX-API-DMAC7.html)
EP (1) EP0649312B1 (cg-RX-API-DMAC7.html)
JP (1) JPH08502519A (cg-RX-API-DMAC7.html)
KR (1) KR100330635B1 (cg-RX-API-DMAC7.html)
CN (1) CN1098106C (cg-RX-API-DMAC7.html)
AT (1) ATE203414T1 (cg-RX-API-DMAC7.html)
AU (1) AU671741B2 (cg-RX-API-DMAC7.html)
CA (1) CA2136438C (cg-RX-API-DMAC7.html)
DE (1) DE69427799T2 (cg-RX-API-DMAC7.html)
DK (1) DK0649312T3 (cg-RX-API-DMAC7.html)
ES (1) ES2161764T3 (cg-RX-API-DMAC7.html)
FI (1) FI112602B (cg-RX-API-DMAC7.html)
GB (1) GB9309663D0 (cg-RX-API-DMAC7.html)
GR (1) GR3036978T3 (cg-RX-API-DMAC7.html)
HU (2) HUT70509A (cg-RX-API-DMAC7.html)
IL (1) IL109528A (cg-RX-API-DMAC7.html)
MY (1) MY110974A (cg-RX-API-DMAC7.html)
NZ (1) NZ265266A (cg-RX-API-DMAC7.html)
PL (1) PL175325B1 (cg-RX-API-DMAC7.html)
PT (1) PT649312E (cg-RX-API-DMAC7.html)
RU (1) RU2145965C1 (cg-RX-API-DMAC7.html)
TW (1) TW268015B (cg-RX-API-DMAC7.html)
UA (1) UA42695C2 (cg-RX-API-DMAC7.html)
WO (1) WO1994026311A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA943212B (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320781D0 (en) * 1993-10-08 1993-12-01 Erba Carlo Spa Polymer-bound camptothecin derivatives
GB9721069D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Polymeric derivatives of camptothecin
GB9721070D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Bioactive derivatives of camptothecin
CA2445985A1 (en) * 2001-05-04 2002-11-14 University Of Utah Research Foundation Hyaluronic acid containing bioconjugates: targeted delivery of anti-cancer drugs to cancer cells
US7049285B2 (en) * 2001-10-31 2006-05-23 Myung-Ok Park Biocompatible polymers including peptide spacer
US20050169883A1 (en) * 2002-05-06 2005-08-04 Prestwich Glenn D. Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents
WO2005004805A2 (en) * 2003-07-02 2005-01-20 Solux Corporation Thermally stable crystalline epirubicin hydrochloride and method of making the same
IL325256A (en) 2014-06-13 2026-02-01 Bach Biosciences Llc FAP-activated medical materials and related uses
WO2015192124A1 (en) * 2014-06-13 2015-12-17 Trustees Of Tufts College Fap-activated therapeutic agents, and uses related thereto

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162512A (en) * 1982-03-09 1992-11-10 Cytogen Corporation Amine derivatives of anthracycline antibodies
JPS60246400A (ja) * 1984-05-22 1985-12-06 Ajinomoto Co Inc アントラサイクリン系化合物及び制ガン剤
GB8614323D0 (en) * 1986-06-12 1986-07-16 Erba Farmitalia Anthracyclines
US5169937A (en) * 1986-11-18 1992-12-08 The Scripps Research Institute Method for producing stable glycosylated hemoglobin
DE3722699A1 (de) * 1987-07-09 1989-01-19 Behringwerke Ag Zytostatisch wirksame anthacyclin-konjugate
CA2014244A1 (en) * 1989-04-13 1990-10-13 Takeda Chemical Industries, Ltd. Stabilized composition of anthracyclines
GB9017024D0 (en) * 1990-08-03 1990-09-19 Erba Carlo Spa New linker for bioactive agents
GB9026491D0 (en) * 1990-12-05 1991-01-23 Erba Carlo Spa Anthracycline-conjugates

Also Published As

Publication number Publication date
RU2145965C1 (ru) 2000-02-27
HU9403811D0 (en) 1995-03-28
PT649312E (pt) 2002-01-30
FI946128A7 (fi) 1994-12-28
CA2136438A1 (en) 1994-11-24
WO1994026311A1 (en) 1994-11-24
DE69427799T2 (de) 2002-05-02
JPH08502519A (ja) 1996-03-19
NZ265266A (en) 1996-06-25
EP0649312B1 (en) 2001-07-25
PL306861A1 (en) 1995-04-18
CN1098106C (zh) 2003-01-08
KR950702201A (ko) 1995-06-19
CA2136438C (en) 2004-09-14
ATE203414T1 (de) 2001-08-15
AU671741B2 (en) 1996-09-05
IL109528A (en) 1998-08-16
IL109528A0 (en) 1994-08-26
UA42695C2 (uk) 2001-11-15
KR100330635B1 (ko) 2002-09-17
DE69427799D1 (de) 2001-08-30
AU6566694A (en) 1994-12-12
ZA943212B (en) 1995-01-18
PL175325B1 (pl) 1998-12-31
HU211538A9 (en) 1995-12-28
EP0649312A1 (en) 1995-04-26
DK0649312T3 (da) 2001-11-12
TW268015B (cg-RX-API-DMAC7.html) 1996-01-11
FI946128A0 (fi) 1994-12-28
FI112602B (fi) 2003-12-31
CN1108454A (zh) 1995-09-13
MY110974A (en) 1999-07-31
RU94046336A (ru) 1996-10-27
HUT70509A (en) 1995-10-30
ES2161764T3 (es) 2001-12-16
GB9309663D0 (en) 1993-06-23
US5571785A (en) 1996-11-05

Similar Documents

Publication Publication Date Title
DK0673258T3 (da) Polymerbundne camptothecinderivater
TW266201B (cg-RX-API-DMAC7.html)
IL108520A0 (en) Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them
BR0111263A (pt) Derivados de 2-aminocarbonil-9h-purina
IL111861A (en) Phenyl-n-substituted azabicycloalkene derivatives and pharmaceutical compositions containing them
GR3034872T3 (en) Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use
IL113160A (en) Lipopeptide a1437 derivatives a process for their preparation and pharmaceutical compositions containing them
AU7585091A (en) Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it
HU9403811D0 (en) Anthracycline conjugates, their preparation and their use as antitumor agents
AU3394793A (en) Substituted aminophosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
UA27108A1 (uk) Аhтрацикліhові глікозиди та їх фармацевтичhо прийhятhі кислотhо-адитивhі солі, спосіб їх одержаhhя, похідhі 1,6-дийод-3-оксапеhтаhу та спосіб їх одержаhhя
DK0819132T3 (da) Fremgangsmåde til fremstilling af anthracyclin-antibiotika
AU3455093A (en) New adenosine derivatives, preparation methods and pharmaceutical compositions containing them
DE3164763D1 (en) Anthracycline glycosides, process for the preparation thereof, intermediate compounds and their preparation and pharmaceutical compositions
MY109729A (en) Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same
HU901424D0 (en) Process for the preparation of thienyl-acetic acid derivatives and pharmaceutical compositions containing such compounds

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees